…
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
| Income before tax | 270.16M | 266.25M | 199.93M | -590.41M | 106.23M |
| Minority interest | 0.96M | -1.50M | -0.87M | -0.92M | -0.75M |
| Net income | 207.56M | 203.21M | 155.98M | -589.37M | 83.63M |
| Selling general administrative | - | - | - | - | 1017.17M |
| Gross profit | 1372.94M | 1289.09M | 1203.13M | 1197.41M | 1190.78M |
| Reconciled depreciation | 83.70M | 81.99M | 78.90M | 82.18M | 82.77M |
| Ebit | 275.97M | 157.00M | 210.61M | 126.44M | 145.89M |
| Ebitda | 387.50M | 266.73M | 303.11M | 208.62M | 228.67M |
| Depreciation and amortization | 111.53M | 109.72M | 92.50M | 82.18M | 82.77M |
| Non operating income net other | 27.83M | 129.54M | 13.61M | 23.50M | 8.18M |
| Operating income | 275.97M | 157.00M | 210.61M | 126.44M | 137.72M |
| Other operating expenses | 6195.50M | 6342.40M | 5701.46M | 5387.07M | 5436.81M |
| Interest expense | 33.64M | 20.29M | 24.28M | 41.79M | 39.67M |
| Tax provision | 63.56M | 64.54M | 44.82M | -1.04M | 23.35M |
| Net interest income | -33.64M | -20.29M | -24.28M | -41.79M | -39.67M |
| Extraordinary items | - | - | - | - | 2.69M |
| Non recurring | - | - | - | 675.05M | - |
| Income tax expense | 63.56M | 64.54M | 44.82M | -1.04M | 23.35M |
| Total revenue | 6471.47M | 6499.40M | 5912.07M | 5490.01M | 5574.52M |
| Total operating expenses | 1096.97M | 1132.09M | 992.52M | 1094.47M | 1053.06M |
| Cost of revenue | 5098.53M | 5210.32M | 4708.94M | 4292.60M | 4383.75M |
| Total other income expense net | -5.81M | 109.25M | -10.68M | -716.84M | 8.18M |
| Net income from continuing ops | 206.60M | 201.71M | 155.11M | -591.45M | 82.88M |
| Net income applicable to common shares | 207.56M | 203.21M | 155.98M | -588.45M | 83.63M |
| Breakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
| Total assets | 2879.15M | 2741.63M | 2751.51M | 2715.35M | 3269.27M |
| Intangible assets | 231.87M | 252.61M | 279.64M | 313.50M | 351.15M |
| Other current assets | 351.01M | 304.24M | 286.67M | 236.10M | 165.60M |
| Total liab | 1760.61M | 1698.99M | 1786.84M | 1878.91M | 1788.76M |
| Total stockholder equity | 1118.54M | 1042.63M | 964.67M | 836.44M | 1480.51M |
| Deferred long term liab | 119.14M | 120.41M | 124.49M | 134.55M | 163.49M |
| Other current liab | 295.95M | 276.00M | 294.40M | 182.10M | 203.32M |
| Common stock | 0.96M | 0.97M | 0.97M | 0.96M | 0.95M |
| Capital stock | 0.96M | 0.97M | 0.97M | 0.96M | 0.95M |
| Retained earnings | 972.13M | 921.70M | 855.74M | 799.65M | 1483.50M |
| Other liab | 156.67M | 141.43M | 161.31M | 153.33M | 185.55M |
| Good will | 156.42M | 140.63M | 139.93M | 138.72M | 816.23M |
| Other assets | 242.46M | 226.45M | 419.35M | 337.41M | 191.36M |
| Cash | 159.67M | 142.01M | 143.24M | 77.94M | 95.65M |
| Total current liabilities | 1085.33M | 1015.67M | 1089.67M | 1074.90M | 875.71M |
| Current deferred revenue | -45.00M | - | - | 134.55M | 22.00M |
| Net debt | 468.33M | 448.22M | 578.62M | 590.38M | 653.67M |
| Short term debt | 109.39M | 58.35M | 186.00M | 30.71M | 23.98M |
| Short long term debt | 81.00M | 29.00M | 153.75M | - | 23.98M |
| Short long term debt total | 628.00M | 590.23M | 721.87M | 668.33M | 749.32M |
| Other stockholder equity | 233.71M | 201.48M | 170.55M | 132.87M | 84.33M |
| Property plant equipment | 212.28M | 213.14M | 219.44M | 303.73M | 305.79M |
| Total current assets | 1783.14M | 1679.02M | 1615.93M | 1542.77M | 1604.36M |
| Long term investments | 160.02M | 277.99M | 223.97M | 214.91M | 113.08M |
| Net tangible assets | 729.24M | 648.43M | 543.64M | 381.89M | 309.88M |
| Net receivables | 477.38M | 447.16M | 449.24M | 416.52M | 582.09M |
| Long term debt | 451.23M | 488.55M | 487.55M | 587.77M | 725.34M |
| Inventory | 795.07M | 785.60M | 736.78M | 812.19M | 761.02M |
| Accounts payable | 724.99M | 681.32M | 609.26M | 862.09M | 648.42M |
| Noncontrolling interest in consolidated entity | 1.00M | 0.96M | 1.46M | 2.33M | 3.25M |
| Accumulated other comprehensive income | -89.26M | -81.52M | -62.59M | -97.04M | -88.27M |
| Common stock total equity | 0.96M | 0.97M | 0.97M | 0.96M | 0.95M |
| Retained earnings total equity | 972.13M | 921.70M | 855.74M | 799.65M | 1483.50M |
| Non currrent assets other | 123.31M | 246.32M | 89.86M | 337.61M | 78.66M |
| Non current assets total | 1096.01M | 1062.61M | 1135.58M | 1172.59M | 1664.91M |
| Capital lease obligations | 95.77M | 72.68M | 80.57M | 80.56M | - |
| Long term debt total | 451.23M | 488.55M | 487.55M | 587.77M | 725.34M |
| Breakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
| Investments | 901.57M | 75.94M | 810.66M | 499.13M | 340.73M |
| Change to liabilities | 21.38M | 53.27M | -182.49M | 245.09M | 44.70M |
| Total cashflows from investing activities | 901.57M | 1239.03M | 810.66M | 499.13M | 340.73M |
| Net borrowings | 14.50M | -124.75M | 53.00M | -164.14M | -265.54M |
| Total cash from financing activities | -126.48M | -253.23M | -22.64M | -271.23M | -355.25M |
| Change to operating activities | -46.28M | -65.52M | 97.51M | -169.56M | -50.29M |
| Net income | 206.60M | 201.71M | 155.11M | -589.37M | 82.88M |
| Change in cash | 17.66M | -1.23M | 65.30M | -17.70M | 32.66M |
| Begin period cash flow | 142.01M | 143.24M | 77.94M | 95.65M | 62.98M |
| End period cash flow | 159.67M | 142.01M | 143.24M | 77.94M | 95.65M |
| Total cash from operating activities | -754.85M | -980.99M | -730.52M | -243.54M | 48.16M |
| Depreciation | 83.70M | 81.99M | 78.90M | 82.18M | 82.77M |
| Other cashflows from investing activities | 980.79M | 1201.39M | 836.45M | 540.94M | 401.46M |
| Dividends paid | 101.35M | 101.11M | 75.18M | 100.44M | 99.47M |
| Change to inventory | -11.09M | -53.87M | 91.19M | -59.26M | 11.55M |
| Change to account receivables | -1047.08M | -1144.83M | -916.69M | 156.52M | 227.91M |
| Sale purchase of stock | -55.49M | -35.00M | - | 0.00M | 0.00M |
| Other cashflows from financing activities | 15.85M | -16.37M | 52.54M | 290.05M | 9.76M |
| Change to netincome | 17.65M | -81.38M | 23.61M | 657.27M | 51.52M |
| Capital expenditures | 64.22M | 38.31M | 25.79M | 41.81M | 60.73M |
| Change receivables | -1047.08M | -1144.83M | -922.50M | 53.81M | 249.52M |
| Cash flows other operating | -26.03M | -37.89M | 25.66M | -633.27M | -391.90M |
| Exchange rate changes | - | - | - | - | -0.98M |
| Cash and cash equivalents changes | 20.23M | 4.80M | 57.50M | -15.64M | 32.66M |
| Change in working capital | -1061.35M | -1185.27M | -996.33M | 126.51M | 251.45M |
| Stock based compensation | 15.54M | 23.80M | 41.25M | 709.88M | 33.42M |
| Other non cash items | 2.65M | -74.72M | 1.32M | -540.94M | -413.13M |
| Free cash flow | -819.07M | -1019.30M | -756.31M | -285.35M | -12.58M |
Sector: Healthcare Industry: Medical Distribution
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MCK McKesson Corporation |
25.76 2.39% |
1102.81 | 24.45 | 20.41 | 0.26 | 5.04 | 0.27 | 15.03 |
| COR Cencora Inc. |
9.65 2.76% |
359.03 | 24.22 | 16.39 | 0.19 | 20.41 | 0.21 | 13.72 |
| CAH Cardinal Health Inc |
2.96 1.06% |
281.10 | 29.48 | 17.92 | 0.20 | 16.07 | 0.22 | 15.67 |
| HSIC Henry Schein Inc |
0.08 0.09% |
86.22 | 25.89 | 15.08 | 0.72 | 3.14 | 1.00 | 13.43 |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
1031 Mendota Heights Road, Saint Paul, MN, United States, 55120
651 686 1600
7600
| Name | Title | Year Born |
|---|---|---|
| Mr. Donald J. Zurbay | CEO, Pres & Director | 1968 |
| Mr. Les B. Korsh | Chief Legal Officer & Corp. Sec. | 1970 |
| Ms. Andrea L. Frohning | Chief HR Officer | 1970 |
| Mr. Kevin M. Pohlman | Pres of Animal Health International, Inc. | 1964 |
| Mr. Kevin Barry | Interim Chief Financial Officer | 1978 |
| Mr. Dave M. Lardy | Chief Information Officer | NA |
| Mr. John M. Wright | VP of Investor Relations | NA |
| Ms. Shivani Prabhakar Kaul | Chief Compliance Officer | NA |
| Mr. Paul A. Guggenheim | Chief Innovation Officer | 1960 |
| Mr. Tim E. Rogan | Pres of Dental | 1971 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.